|Articles|October 16, 2020
Evaluation of New High pH Stable, Superficially-porous Particle Columns for the Reversed-phase Separation of Oligonucleotides
Author(s)Agilent
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
Developing Next-Gen Cell Lines Using Targeted Integration
2
Norgine Secures Hepatitis Delta Therapy Rights Across Key Region
3
FDA-Approved WAS Gene Therapy Hits Market in Nonprofit Model
4
EU Clears Subcutaneous Biologic for Lupus, Advancing Patient-Controlled Delivery
5